Evaluating the Anti-Inflammatory Effects of Curcumin Supplementation in Adult Populations
TL;DR
Increasing evidence suggests that elevated circulating biomarkers such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) are strongly associated with disease progression, reduced quality of life, and increased mortality among adult populations.
Abstract
Chronic inflammation has emerged as one of the principal biological mechanisms underlying the global burden of non-communicable diseases (NCDs), including cardiovascular disease, type 2 diabetes mellitus, obesity, osteoarthritis, metabolic syndrome, neurodegenerative disorders, and several forms of cancer. Unlike acute inflammation, which is essential for host defense and tissue repair, chronic low-grade inflammation is characterized by persistent activation of immune pathways, excessive production of pro-inflammatory cytokines, and prolonged oxidative stress that gradually impair tissue function. Increasing evidence suggests that elevated circulating biomarkers such as C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) are strongly associated with disease progression, reduced quality of life, and increased mortality among adult populations. Consequently, identifying safe and effective anti-inflammatory interventions has become an important priority in preventive medicine and clinical nutrition.